Company Filing History:
Years Active: 2022-2026
Title: Ellen James: Innovator in Pharmaceutical Formulations
Introduction
Ellen James is a prominent inventor based in London, GB. She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of innovative therapies for psychiatric and neurological disorders. With a total of 7 patents to her name, her work is paving the way for new treatment options.
Latest Patents
Ellen's latest patents include groundbreaking formulations that focus on injectable and inhalable methods. One of her notable inventions relates to aqueous pharmaceutical formulations that comprise a salt of an optionally substituted dimethyltryptamine compound. These formulations are designed for use in psychedelic-assisted therapy and can be administered through intramuscular injection or nebulized inhalation. The formulations are stable, clinically acceptable, and have potential applications in treating various psychiatric or neurological disorders. Additionally, she has developed deuterated or partially deuterated N,N-dimethyltryptamine compounds, which offer tailored therapeutic effects through varying compositions.
Career Highlights
Throughout her career, Ellen has worked with notable companies such as Small Pharma Ltd and Cybin UK Ltd. Her innovative approach and dedication to research have positioned her as a key player in the pharmaceutical industry.
Collaborations
Ellen has collaborated with esteemed colleagues, including Peter Rands and Tiffanie Benway, to further advance her research and development efforts.
Conclusion
Ellen James is a trailblazer in the field of pharmaceutical innovations, with her patents reflecting her commitment to improving mental health treatments. Her work continues to inspire advancements in therapeutic applications.